Page 130 - 南京医科大学自然版
P. 130

第46卷第10期
               ·1560 ·                           南 京    医 科 大 学 学         报                        2026年10月


                   ASAIO J,2024,70(7):586-593                        ation[J]. J Thorac Dis,2024,16(2):1097-1107
             [14]Ramsarran J,Albertson T,Hoops T,et al. Investigating  [20]Ning Y L,Guan T X,Niu X L,et al. Vasoactive⁃inotropic
                   biomarkers associated with mortality in patients receiving  score reduction rate is highly associated with prognosis
                   VA⁃ECMO for cardiogenic shock:a systematic review[J].  for critically Ⅲ patients with cardiogenic shock:insights
                   J Osteopath Med,2026,126(7):305-312               from the real⁃world dynamic data[J]. Cardiovasc Ther,
             [15]Celińska⁃Spodar M,Załęska Kocięcka M,Kowalik I,et   2026,2026:8989505
                   al. Troponin T and survival following cardiac surgery in  [21]Thao L T P,Buscher H,Nguyen T L,et al. Liberal or re⁃
                   patients supported with extracorporeal membrane oxygen⁃  strictive transfusion for veno⁃arterial extracorporeal mem⁃
                   ation for post⁃cardiotomy shock[J]. Diagnostics(Basel),  brane oxygenation patients:a target trial emulation using
                   2023,14(1):45                                     the OBLEX study data[J]. Crit Care,2025,29(1):360
             [16]李    伟,陈旭锋,梅      勇,等.心肌肌钙蛋白T 对接受静             [22]Soar J,Böttiger B W,Carli P,et al. European Resuscita⁃
                   脉⁃动脉体外膜肺氧合治疗的心源性休克患者预后的                           tion Council Guidelines 2021:adult advanced life sup⁃
                   预测价值:一项连续5年回顾性研究[J].中华危重病急                        port[J]. Resuscitation,2021,161:115-151
                   救医学,2020,32(9):1091-1095                     [23]Rajsic S,Tauber H,Breitkopf R,et al. Mortality predic⁃
                   Li W,Chen X F,Mei Y,et al. Value of cardiac troponin T  tors and neurological outcomes following extracorporeal
                   in predicting the prognosis of patients with cardiogenic  cardiopulmonary resuscitation(eCPR):a single ⁃ center
                   shock receiving veno⁃arterial extracorporeal membrane ox⁃  retrospective study[J]. J Cardiovasc Dev Dis,2024,11
                   ygenation treatment:a consecutive 5 ⁃ year retrospective  (9):272
                   study[J]. Chinese Critical Care Medicine,2020,32(9):  [24]Tran A,Rochwerg B,Fan E,et al. Prognostic factors asso⁃
                   1091-1095                                         ciated with favourable functional outcome among adult pa⁃
             [17]Laurent I,Monchi M,Chiche J D,et al. Reversible myo⁃  tients requiring extracorporeal cardiopulmonary resuscita⁃
                   cardial dysfunction in survivors of out⁃of⁃hospital cardiac  tion for out⁃of⁃hospital cardiac arrest:a systematic review
                   arrest[J]. J Am Coll Cardiol,2002,40(12):2110-2116  and meta⁃analysis[J]. Resuscitation,2023,193:110004
             [18]Dunton K,Weeks P A,Gulbis B,et al. Evaluation of vaso⁃  [25]Perman S M,Elmer J,Maciel C B,et al. 2023 American
                   active ⁃ inotropic score and survival to decannulation in  Heart Association Focused Update on adult advanced car⁃
                   adult patients on venoarterial extracorporeal life support:  diovascular life support:an update to the American Heart
                   an observational cohort study[J]. ASAIO J,2023,69(9):  Association Guidelines for cardiopulmonary resuscitation
                   873-878                                           and emergency cardiovascular care[J]. Circulation,2024,
             [19]Hu Y,Wang L,Yang F,et al. Prognostic implication of va⁃  149(5):e254-e273
                  soactive inotropic score in adult patients with cardiogenic  (收稿:2026-06-24;修回:2026-09-05;录用:2026-09-07)
                  shock on veno⁃arterial extracorporeal membrane oxygen⁃                      (本文编辑:唐       震)

              

             (上接第1510页)

                   志,2023,27(2):238-243                              hepatitis B virus epidemiology in China:current status,
                   Jiang J,Qian J,Zhu L G,et al. Comparative analysis on  changing trajectory,and challenges[J]. Hepatobiliary
                   seroprevalence of hepatitis B in 2010 and 2020 in Ji⁃  Surg Nutr,2025,14(1):66-77
                   angsu Province[J]. Chinese Journal of Disease Control &  [27]Zheng H,Wang Y,Wang F Z,et al. New progress in HBV
                   Prevention,2023,27(2):238-243                     control and the cascade of health care for people living
             [25]付思美,曹博楠,李          响,等. 2024 年吉林省乙型肝炎               with HBV in China:evidence from the fourth national se⁃
                   病毒血清流行病学及基因分型研究[J]. 中华实验和临                        rological survey,2020[J]. Lancet Reg Health West Pac,

                   床病毒学杂志,2025,39(4):461-467                         2024,51:101193
                   Fu S M,Cao B N,Li X,et al. Investigation and analysis  [28]Qi X Y,Hu Y Z,Jiang W. Epidemiological trends and pro⁃
                   on hepatitis B serum epidemiology and genotyping in Jilin  jections to 2035 of hepatitis B burden in China,1990-
                   province in 2024[J]. Chinese Journal of Experimental  2021[J]. PLoS One,2025,20(9):e0330633
                   and Clinical Virology,2025,39(4):461-467      (收稿:2025-10-24;修回:2026-01-25;录用:2026-02-06)
             [26]Yan R Y,Sun M H,Yang H Y,et al. 2024 latest report on                        (本文编辑:陈汐敏)
   125   126   127   128   129   130   131   132   133   134   135